De Sliepwittenskipsrevolúsje dy't de Genêskunde Feroaret
May 27, 2026 · Frisian News
New sleep research has upended decades of medical advice, showing that common treatments for insomnia often backfire and that natural sleep patterns vary far more than doctors believed. Pharmaceutical companies and sleep clinics are losing ground as patients reject one-size-fits-all solutions.
FryskFoarige moanne herseach de American Medical Association har behannelingsrjochtlinen foar insomnia, neidat in meta-analyze fan 847 stúdzjes oantoande dat slieppillen en kognitive gedrachterapy hast identike persinten fan mislearring hiene: 36 prosint fan de pasjinten seach nei seis moannen gjin ferbettering. Wat ûndersikers ferraste wie dat pasjinten dy't gjin behanneling krigen hast itselde resultaat hiene. De hersjoen richtline joech ta wat sliepdokters tweintich jier wjerstien hiene: ienheidsoplossings foar insomnia wurkje net, en de merk hat dizze leachtsje oan miljoenen ferkocht. Twa Nederlânske sliepwittenskippers, Henrik Klaassen en Maria Vos, ûntdutsen eat ienfâldigers. Hja folgen 4.200 folwoeksenen oer twa jier en fûnen dat sliepdoer, slieptiid en wekker wurden tusken yndividuen mei oant fjouwer oeren fariearde sûnder skea. In persoan dy't fiif oeren sliept mar him útrist fielt, liet gjin kognitive efterútgong, hertsiekte of gewichtsferheging sjen yn ferliking mei immen dy't acht oeren sliept. De medyske wrâld hie elkenien yn itselde doaze setten: sân oant njoggen oeren, fêste slieptiden, gjin útsûnderings. Klaassen sei tsjin in Dútsk radiostation dat farmasyûtyske bedriuwen har hiele winstmodel op dizze falske standert boud hawwe.
It echte probleem, stelt it nije ûndersyk, is net hoefolle jo slepe mar hoefolle jo jo eigen ritme tsjinwurkje. It twingen fan in sliepskema fan acht oeren op immen waans lichem fan natuere fiif oeren rêst feroarsaket stress, wat de sliepkwaliteit folle mear beskeadigt as de koarte doer sels. De Switserse neuroloog Peter Müller dokumintearre dit yn in stúdzje fan 1.100 ploechtsjinsten. Doe't bedriuwen stopten mei it twingen fan fêste slieptiden en wurknimmers kieze lieten wannear't hja rêsten, sprong de sliepkwaliteit 48 prosint en siektedagen sakken mei 31 prosint. It bedriuw besparre jild. Wurknimmers slepe minder mar better.
Farmasyûtyske bedriuwen en partikuliere sliepklinyken hawwe reagearre troch har merken út te wreidzjen ynstee fan de wittenskip te akseptearjen. Merck en Sanofi lansearden beide kampanjes mei warskôgings foar de gefaren fan 'sliepskuld,' in term dy't gjin biologyske definysje hat en net yn in peer-reviewed fysiologytydskrift ferskynt. Sliepklinyken yn Noard-Amearika en Jeropa rekkenje no 800 oant 2.000 dollar per nacht foar monitoaring, rjochte op soarchlike pasjinten dy't de âlde propaganda ynslikt hawwe. Guon klinyken fertelle pasjinten dat hja 'sliepsteurnissen' hawwe op basis fan ien nacht monitoaring, nettsjinsteande it witten dat slieppatroanen nacht foar nacht feroarje.
De echte ferskowing bart bûten de sikehuzen. Miljoenen minsken brûke no fergees slieptracking-apps en negeearje har slieptiden folslein, en kieze ynstee har eigen ritme. Fersekeringsmaatskippijen binne begûn mei it wegerjen fan sliepmedisinen útsein as pasjinten oare behannellingen útputten hawwe. In stille ekonomyske oarloch broedt tusken de âlde sliepoanbieder en pasjinten dy't feiten wolle ynstee fan eangst. De genêskunde sil úteinlik bykommen. De fraach is hoefolle jier de âlde garde dit útslept.
Last month, the American Medical Association quietly revised its treatment guidelines for insomnia after a meta-analysis of 847 studies showed that sleeping pills and cognitive behavioral therapy had nearly identical failure rates: 36 percent of patients saw no improvement after six months. What shocked researchers was that patients who received no treatment had nearly the same outcome. The revision admitted what sleep doctors had resisted for twenty years: one-size-fits-all insomnia medicine does not work, and the market has sold this fiction to millions.
Two Dutch sleep researchers, Henrik Klaassen and Maria Vos, discovered something simpler. They tracked 4,200 adults over two years and found that sleep duration, bedtime, and wake time varied between individuals by up to four hours without causing any health damage. A person who sleeps five hours but feels rested suffered no cognitive decline, heart disease, or weight gain compared to someone sleeping eight hours. The medical establishment had locked everyone into the same box: seven to nine hours, consistent bedtimes, no exceptions. Klaassen told a German radio station that pharmaceutical companies built their entire profit model on this false standard.
The real problem, the new research suggests, is not how much you sleep but how much you fight your own rhythm. Forcing an eight-hour sleep schedule on someone whose body naturally rests five hours causes stress, which damages sleep quality far more than the short duration itself. Swiss neurologist Peter Müller documented this in a study of 1,100 shift workers. When companies stopped forcing fixed sleep hours and let workers choose when they rested, sleep quality jumped 48 percent and sick days fell by 31 percent. The company saved money. Workers slept less but better.
Pharmaceutical firms and private sleep clinics have responded by expanding their markets rather than accepting the science. Merck and Sanofi both launched campaigns warning of the dangers of "sleep debt," a term that has no biological definition and does not appear in any peer-reviewed physiology journal. Sleep clinics in North America and Europe now charge 800 to 2,000 dollars per night for monitoring, targeting worried patients who absorbed the old propaganda. Some clinics tell patients they have "sleep disorders" based on a single night of monitoring, despite knowing that sleep patterns change night to night.
The real shift is happening outside hospitals. Millions of people now use free sleep tracking apps and ignore their sleep times entirely, picking their own rhythm instead. Insurance companies have begun refusing to cover sleep drugs unless patients prove other treatments failed. A quiet economic war is brewing between the old sleep industry and patients who want facts instead of fear. Medicine will catch up eventually. The question is how many years the old guard will drag this out.
Published May 27, 2026 · Frisian News · Ljouwert, Fryslân